SonderMind acquires technology from Mindstrong ahead of digital health startup’s shutdown

Mindstrong’s collapse comes in a turbulent period for the digital health sector.

By Nick Paul Taylor • March 23, 2023

NuVasive shareholders expected to ‘begrudgingly’ back Globus’ $3.1B takeover amid lack of other bidders

Analysts said “none of the other major strategic players were in a position to bid on NuVasive — either because they were not interested or were financially tied up in other areas.”

By Nick Paul Taylor • March 22, 2023

Explore the Trendline➔

More mergers, new diabetes devices and the road to MDR: Medtech trends in 2023

Medical device leaders expect financial pressures to ease as companies navigate regulatory changes in Europe, planned spinoffs and product launches.

By MedTech Dive staff

Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail

The DNA-sequencing company said the activist investor hasn’t offered any better solutions for satisfying regulators’ concerns about the acquisition.

By Susan Kelly • March 20, 2023

Getinge buys sterilization firm Ultra Clean Systems for $16M

The Sweden-based company, which already partnered with Ultra Clean as a distributor, said the deal will “significantly expand” its offerings to sterile reprocessing departments.

By Elise Reuter • March 15, 2023

Illumina shares jump 17% after Icahn launches proxy fight

The activist investor said his board nominees would work to prevent Illumina from “sinking further into the quicksand” in a battle with regulators over the Grail acquisition.

By Susan Kelly • Updated March 14, 2023

Olympus agrees to $370M gastrointestinal stent takeover as medtech M&A rebound continues

The deal for Korea-based Taewoong, which makes stents used to help clear blockages, supports Olympus’ plan to expand in the GI market.

By Nick Paul Taylor • Feb. 28, 2023

Globus’ full-year sales top $1B as analysts continue to question wisdom of NuVasive takeover

Analysts raised concerns about Globus’ planned $3.1 billion takeover of spine specialist NuVasive, asking about the company’s “flexibility and willingness to close the deal.” 

By Nick Paul Taylor • Feb. 23, 2023

Insulet pays Bigfoot Biomedical $25M for pump-based automated insulin delivery technology

Insulet framed the Bigfoot deal as a way to double its IP portfolio and strengthen its position in the insulin pump market.

By Nick Paul Taylor • Feb. 14, 2023

GE HealthCare agrees to buy AI imaging firm Caption Health in second acquisition

GE HealthCare plans to pair its ultrasound machines with Caption’s applications for early disease detection.

By Elise Reuter • Feb. 10, 2023

Abbott to pay $890M to acquire CSI, gaining atherectomy device

The deal expands Abbott’s vascular device lineup and access to additional products in development.

By Susan Kelly • Feb. 9, 2023

Globus agrees to buy NuVasive in stock deal valued at $3.1B, boosting spine business

The two firms expect their combined salesforce and shared operational strengths will better fend off competition.

By Elise Reuter • Updated Feb. 9, 2023

Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report

Manufacturers that serve other industries are expected to move into medtech through mergers and acquisitions, driving up deal volumes.

By Nick Paul Taylor • Feb. 9, 2023

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.

By Peter Green • Jan. 31, 2023

Bayer to buy AI imaging platform Blackford Analysis to bolster radiology growth strategy

Bayer aims to outpace the broader radiology segment by investing in fast-growing technologies such as imaging AI.

By Elise Reuter • Updated Jan. 18, 2023

Shockwave to pay $100M for Neovasc, adding refractory angina treatment to device pipeline

Neovasc already has a CE mark for the device and last year said it was targeting a 2025 approval by the FDA.

By Nick Paul Taylor • Jan. 18, 2023

‘Mixed signals’ from medtech management suggest industry had bumpy end to 2022: analysts

The recovery of procedure volumes was “muted and uneven” in the fourth quarter with growth throttled by hospital staffing issues and worker absenteeism.

By Nick Paul Taylor • Jan. 13, 2023

GE HealthCare to buy France’s IMACTIS in first acquisition as independent firm

IMACTIS’s CT-Navigation system is used to help surgeons in minimally invasive operations and reduce procedure time. 

By Peter Green • Jan. 11, 2023

Medtronic CEO Martha: No more divestitures planned for 2023, but review continues

“The portfolio review is ongoing,” CEO Geoff Martha said, even as the world's largest medtech company plans to divest dialysis, respiratory interventions and patient monitoring businesses.

By Elise Reuter • Jan. 9, 2023

Baxter to spin off renal care, acute therapies units

The company is also considering the sale of its Biopharma Solutions business.

By Elise Reuter • Jan. 6, 2023

Friday Q&A: For GE HealthCare, the future is digital, CEO Arduini says

Digital capabilities will be “the next big inflection” driving growth for GE’s newly independent healthcare business. 

By Peter Green • Jan. 6, 2023

Zimmer to acquire soft tissue repair firm Embody for as much as $275M

Buying Embody’s repair system for tendons and ligaments will expand Zimmer Biomet’s share in the growing sports medicine market.

By Elise Reuter • Jan. 5, 2023

A look back at medtech’s top 10 acquisitions of 2022

While larger acquisitions were announced at the end of the year including J&J’s $16.6B purchase of Abiomed, the number of deals declined from 2021.

By Elise Reuter • Dec. 22, 2022

J&J closes acquisition of heart pump maker Abiomed

The $16.6 billion purchase was the largest medtech transaction of 2022.

By Elise Reuter • Dec. 22, 2022

Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision

The acquisition gives Olympus control of cloud-based AI systems to help detect and characterize cancerous and precancerous tissues during colonoscopies and gastroscopies.

By Nick Paul Taylor • Dec. 21, 2022

Fujifilm agrees to buy Inspirata’s Dynamyx in challenge to Philips for digital pathology market

Fujifilm struck the deal after customers told it “digitizing pathology will be the most transformative thing they do for their practice.”

By Nick Paul Taylor • Dec. 21, 2022